Literature DB >> 12580404

Mechanisms underlying hypoxia development in tumors.

Mark W Dewhirst1.   

Abstract

Entities:  

Mesh：

Year:  2003        PMID： 12580404     DOI： 10.1007/978-1-4615-0205-0_9

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN： 0065-2598            Impact factor:   2.622


× No keyword cloud information.
  5 in total

1.  Hypoxia-Activated Prodrug Evofosfamide Treatment in Pancreatic Ductal Adenocarcinoma Xenografts Alters the Tumor Redox Status to Potentiate Radiotherapy.

Authors:  Shun Kishimoto; Jeffrey R Brender; Gadisetti V R Chandramouli; Yu Saida; Kazutoshi Yamamoto; James B Mitchell; Murali C Krishna
Journal:  Antioxid Redox Signal       Date:  2020-09-15       Impact factor: 7.468

Review 2.  Novel imaging provides new insights into mechanisms of oxygen transport in tumors.

Authors:  Matthew E Hardee; Mark W Dewhirst; Nikita Agarwal; Brian S Sorg
Journal:  Curr Mol Med       Date:  2009-05       Impact factor: 2.222

3.  Targeting lactate-fueled respiration selectively kills hypoxic tumor cells in mice.

Authors:  Pierre Sonveaux; Frédérique Végran; Thies Schroeder; Melanie C Wergin; Julien Verrax; Zahid N Rabbani; Christophe J De Saedeleer; Kelly M Kennedy; Caroline Diepart; Bénédicte F Jordan; Michael J Kelley; Bernard Gallez; Miriam L Wahl; Olivier Feron; Mark W Dewhirst
Journal:  J Clin Invest       Date:  2008-11-20       Impact factor: 14.808

Review 4.  HIF-1 and tumour radiosensitivity.

Authors:  B J Moeller; M W Dewhirst
Journal:  Br J Cancer       Date:  2006-05-30       Impact factor: 7.640

5.  Targeting the tumour vasculature: exploitation of low oxygenation and sensitivity to NOS inhibition by treatment with a hypoxic cytotoxin.

Authors:  Jennifer H E Baker; Alastair H Kyle; Kirsten L Bartels; Stephen P Methot; Erin J Flanagan; Andrew Balbirnie; Jordan D Cran; Andrew I Minchinton
Journal:  PLoS One       Date:  2013-10-28       Impact factor: 3.240
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.